| JXSL2300107 | 戈利木单抗注射液 | golimumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-06-16 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JYSB2400070 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2024-04-02 | | Janssen Biologics BV;Cilag AG | | | view |
| JYSB2200117 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2022-07-07 | | Janssen Biologics BV;Cilag AG | | | view |
| CXSS2500036 | 戈利木单抗注射液 | golimumab | Injection | Biological Products(3.3) | New Drug Application | 2025-03-13 | | Bio-Thera Solutions Ltd | | | view |
| JYSB2400071 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2024-04-02 | | Janssen Biologics BV;Cilag AG | | | view |
| JYSZ2400030 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | License Renew | 2024-05-25 | | Janssen Biologics BV;Cilag AG;Xian Janssen Pharmaceutical Ltd | | | view |
| JYSB2101095 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2021-07-27 | | Janssen Biologics BV;Cilag AG | | | view |
| JYSB2300162 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2023-09-15 | | Janssen Biologics BV;Cilag AG | | | view |
| JYSB2200116 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2022-07-07 | | Janssen Biologics BV;Cilag AG | | | view |
| JYSB2101096 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2021-07-27 | | Janssen Biologics BV;Cilag AG | | | view |
| JYSB2300161 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2023-09-15 | | Janssen Biologics BV;Cilag AG | | | view |
| JXSL2200034 | 戈利木单抗注射液 | golimumab | Injection | Biological Products(2.2) | Import Drug Application | 2022-03-22 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JYSZ2400029 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | License Renew | 2024-05-25 | | Janssen Biologics BV;Cilag AG;Xian Janssen Pharmaceutical Ltd | | | view |
| JXSL1000057 | 人源抗-TNFα单克隆抗体(CNTO 148)注射剂 | golimumab | Injection | Biological Products | Import Drug Application | 2010-12-17 | Centocor B.V. | Centocor BV | Certificate Issued | 2013-11-15 | view |
| JXSR1400001 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | State Standards | 2014-09-25 | Janssen Biologics B.V. | Janssen Biologics BV;Baxter Pharmaceutical Solutions LLC | Certificate Issued | 2018-04-25 | view |
| JYSB2000334 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2020-06-28 | Janssen Biologics B.V. | Janssen Biologics BV;Cilag AG | Filed | 2020-07-01 | view |
| JYSB2100090 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2021-04-01 | Janssen Biologics B.V. | Janssen Biologics BV;Cilag AG | In Review | 2021-03-31 | view |
| JYSB1800200 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2018-09-29 | Janssen Biologics B.V. | Janssen Biologics BV;Baxter Pharmaceutical Solutions LLC | Certificate Issued | 2019-05-06 | view |
| JXSS1400007 | CNTO 148单抗注射液 | golimumab | Injection | Biological Products | Import Drug Application | 2014-07-17 | Janssen Biologics B.V. | Janssen Biologics BV;Baxter Pharmaceutical Solutions LLC | Certificate Issued | 2018-01-04 | view |
| JYSB1900231 | 戈利木单抗注射液 | golimumab | Injection | Biological Products | Supplementary Application | 2019-09-04 | Janssen Biologics B.V. | Janssen Biologics BV;Cilag AG | Certificate Issued | 2020-08-18 | view |
